retatrutide liver damage does affect Researchers report promising results with retatrutide, which significantly reduced fat in some patients over several months. Excess liver fat causes metabolic dysfunction–associated steatotic liver disease (MASLD Retatrutide for weight loss: Study

Lipoxidation in cardiovascular diseases

This was a landmark moment because it represented global recognition of GLP-1 medications as a legitimate long-term treatment for obesity rather than a temporary or supplementary intervention

Additional ongoing trials of AOM in patients with cardiovascular disease, including HFpEF, will further improve insight into the potential role of managing obesity to improve HF status among patients with HFpEF and obesity

Patients often say that hair feels stronger or denser after months of treatment

You can send an email to [email protected] or submit your request at the bottom of the page

Medicare provides very little coverage for the most needed services that home health care agencies and aides perform